Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS)

This study has been completed.
Information provided by Neurocrine Biosciences

Please refer to this study by its ClinicalTrials.gov identifier: NCT00079495

Sponsors and Collaborators

Investigators